The Dr Thibaud Lebouvier, neurologist at the Memory Center of the Lille University Hospital has received a grant to conduct the CAFCA clinical trial. This clinical trial aims to measure the capacity of coffee (more precisely cafeine) to slow down/prevent the symptoms of Alzheimer disease.
This project is in collaboration with Dr David Blum of the “Alzheimer and Tauopathy” team of the JP AUbert Research center in Lille
A free MOOC on “Parkinson disease” is now available (French language). It invites you to discover this disease on which research is still intense. What are the first clinical signs? What are the causes? What is happening inside the brain? Is it a disease of the motor memory? How to treat it? What are the new therapies under developpement? The MOOC registration is already open and first training are starting on the 1rst of october 2018.
The LiCEND at the “Village des Sciences” – 11th to 14h of October 2018 – Gare St Sauveur – Lille
The LiCend will participate to the 2018 edition of the Village des Sciences which will take place in the Gare Saint Sauveur in Lille from the 11th to the 14th of October 2018. The topic of the year 2018 is the “Error”. The Licend will propose activities about the brain functions, optical tricks, neurodegenerative diseases and how to detect brain errors with EEG and MRI.
International Conference on Cerebral Amyloid Angiopathy – 6 au 8 septembre 2018 – Lille
The 2018 Lille conference will bring together international leaders in laboratory- and patient-based research and clinical care in the rapidly growing and increasingly recognized field of cerebral amyloid angiopathy, one of the two major sporadic small vessel brain diseases. The conference will be held at the School of Medicine – ‘Pôle Recherche’ in Lille, France.
The LiCEND, Lille Center of Excellence on Neurodegenerative Diseases, and it partners had the pleasure to organize the french conference on Alzheimer disease and associated diseases “Réunion Francophone sur la Maladie d’Alzheimer et Syndromes Apparentés” (RFMASA) which took place from the 11th to 14th of June 2018 at the Faculty of Medicine of Lille.
A complementary training on Frontal temporal dementia was also proposed : seeHere
The RFMASA 2018 program has focused on:
The crucial role of the patients and their close relatives in clinical researches (partnership with patients’ associations)
The specificities of Young patients with Alzheimer disease;
Innovative strategies for a transdisciplinary researches (in association with the DISTALZ Labex)
Impact of Vascular and metabolic risk factors (in association with the FHU VasCog)
Statification and nosography in Clinical and tharpeutical research;
Big Data and new technologies;
Recent findings of basic research
Early diagnosis through clinico-pathological cases;
We thanks again all attendees for the excellent presentation and the interesting discussion held during the congress